Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2003
11/13/2003WO2003093455A2 Adenovirus vectors for immunotherapy
11/13/2003WO2003093422A2 Novel tissue factor targeted antibodies as anticoagulants
11/13/2003WO2003093297A2 Protein kinase modulators and methods of use
11/13/2003WO2003093290A2 Nucleoside derivatives for treating hepatitis c virus infection
11/13/2003WO2003093289A1 Tricyclic macrolide antibacterial compounds
11/13/2003WO2003093288A1 Antibacterial compounds with improved pharmacokinetic profiles
11/13/2003WO2003093280A1 Heterotricyclyl 6-alkylidene-penems as βετα-lactamase inhibitors
11/13/2003WO2003093279A1 BICYCLIC 6-ALKYLIDENE-PENEMS AS ß-LACTAMASES INHIBITORS
11/13/2003WO2003093263A1 Substituted imidazole derivatives: gabaa receptor ligands
11/13/2003WO2003093261A1 Phthalazinone derivatives
11/13/2003WO2003093258A2 Novel spiro ketone and carboxylic acid derivatives as specific inhibitors for (po3h2) ser/(po3h2)thr-pro-specific peptidyl-prolyl-cis/trans-isomerases
11/13/2003WO2003093249A1 Thiazolidinones and the use thereof as polo-like kinase inhibitors
11/13/2003WO2003093248A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
11/13/2003WO2003093240A1 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
11/13/2003WO2003093234A1 Melanocortin receptor ligands
11/13/2003WO2003092740A1 Non-viral gene delivery system
11/13/2003WO2003092739A1 Non-viral gene delivery system
11/13/2003WO2003092732A1 Ph-sensitive polymer
11/13/2003WO2003092718A2 Treatment and inhibition of ocular infections and wounds by cap37 and cap37 peptides
11/13/2003WO2003092712A1 Use of mastic and its components for the control of microbial infections
11/13/2003WO2003092706A1 Re-epithelializing pharmaceutical compositions comprising xanthan gum
11/13/2003WO2003092704A1 External preparation enhanced in systemic property of vidarabine
11/13/2003WO2003092699A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
11/13/2003WO2003092691A1 Combination of cyclooxygenase-2 inhibitors and thalidomide for the treatment of neoplasia
11/13/2003WO2003092690A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
11/13/2003WO2003092686A1 Inhibitors of histone deacetylase
11/13/2003WO2003092678A1 1-substituted imidazole derivatives as nos inhibitors
11/13/2003WO2003092667A1 Composition for treating cancer containing n,n-dimethylphytosphingosine
11/13/2003WO2003092660A1 Monocompartment osmotic controlled drug delivery system
11/13/2003WO2003092654A1 Formulations limiting spread of pulmonary infections
11/13/2003WO2003092652A1 Warming and nonirritating anhydrous lubricant compositions
11/13/2003WO2003092651A1 Warming and nonirritating lubricant compositions
11/13/2003WO2003092633A2 Diffusion-controlled dosage form and method of fabrication including three dimensional printing
11/13/2003WO2003092629A2 Methods of simultaneously treating mucositis and fungal infection
11/13/2003WO2003092624A2 Use of heat shock proteins to enhance efficacy of antibody therapeutics
11/13/2003WO2003092613A2 Catechin multimers as therapeutic drug delivery agents
11/13/2003WO2003092610A2 Methods of using cytokine antagonists to treat hiv infection and aids
11/13/2003WO2003092608A2 Methionine aminopeptidase-2 inhibitors and methods of use thereof
11/13/2003WO2003092605A2 Protease inhibitors
11/13/2003WO2003092602A2 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
11/13/2003WO2003092600A2 Site specific listeria integration vectors and methods for using the same
11/13/2003WO2003092599A2 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent
11/13/2003WO2003092592A2 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
11/13/2003WO2003092588A2 4-azasteroid derivatives as androgen receptor modulators
11/13/2003WO2003092585A2 Controlled release compositions of estradiol metabolites
11/13/2003WO2003082864A3 Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
11/13/2003WO2003075825A3 The method of treating tuberculosis
11/13/2003WO2003075788A3 Biodegradable microbicidal vaginal barrier device
11/13/2003WO2003066621A8 Piperidine derivatives and their use as antagonists of tachykinins
11/13/2003WO2003066001A3 Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
11/13/2003WO2003064447A3 Immune-modulating peptide
11/13/2003WO2003061554A3 Composition containing moutan root bark extract as active ingredient
11/13/2003WO2003060143A3 Efficient protein expression system
11/13/2003WO2003051392A3 Streptococcus pneumoniae vaccine
11/13/2003WO2003039444A3 Topical use of cytokines and/or chemokines for the treatment of viral or mykotic skin diseases or tumoral diseases
11/13/2003WO2003033653A3 Affinity enhancement agents
11/13/2003WO2003032948A3 Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity
11/13/2003WO2003031459A3 Modulation of the expression of genes dependent on stat-1
11/13/2003WO2003031407A3 β-LACTAMYL VASOPRESSIN VlaANTAGONISTS
11/13/2003WO2003030944A3 Inhibition of stat-1
11/13/2003WO2003029436A3 Ul16 binding protein 4
11/13/2003WO2003022360A3 Thermotherapy via targeted delivery of nanoscale magnetic particles
11/13/2003WO2003018134A3 Bioadhesive compositions and methods for enhanced mucosal drug absorption
11/13/2003WO2003013432A3 Methods of use for novel sulfur containing organic nitrate compounds
11/13/2003WO2003012111A3 Conjugates for the modulation of immune responses
11/13/2003WO2003009778A3 Methods and devices for delivery of therapeutic capable agents with variable release profile
11/13/2003WO2002099115A3 Nucleic acid-associated proteins
11/13/2003WO2002098443A3 Stabilised mrna with an increased g/c content and optimised codon for use in gene therapy
11/13/2003WO2002094250A3 Therapeutic uses of lna-modified oligonucleotides in infectious diseases
11/13/2003WO2002088137A9 Pkb-3564 substance with neovascularization inhibitory activity
11/13/2003WO2002079243A3 Gonococcal proteins and nucleic acids
11/13/2003WO2002072031A3 Substituted tetracycline compounds as synergistic antifungal agents
11/13/2003WO2002058629A3 Stable aqueous antimicrobial suspension
11/13/2003WO2002057302A8 A virus causing respiratory tract illness in susceptible mammals
11/13/2003WO2002057226A8 68730 and 69112 protein kinase molecules and uses therefor
11/13/2003WO2002056893A8 Novel receptors for $i(helicobacter pylori) and use thereof
11/13/2003WO2002051404A8 Compositions for oral use
11/13/2003WO2002050030A8 Cycloalkylfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
11/13/2003WO2002050029A8 Tetracyclic derivatives as spla2 inhibitors
11/13/2003WO2002032874A8 Substituted heterocyclic compounds for treating multidrug resistance
11/13/2003WO2002014362A3 A hepatitis c virus non-structural ns3/4a fusion gene
11/13/2003US20030212138 Synergistic mixture; analgesics, antiinflammatory agents, cardiovascular disorders, anticancer agents
11/13/2003US20030212114 Stable emulsion compositions
11/13/2003US20030212113 Novel aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity
11/13/2003US20030212093 Imidazonaphthyridines
11/13/2003US20030212092 Aryl ether substituted imidazoquinolines
11/13/2003US20030212091 Aryl ether substituted imidazoquinolines
11/13/2003US20030212084 Naphthrydine compounds and their azaisosteric analogues as antibacterials
11/13/2003US20030212073 Imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof
11/13/2003US20030212068 Antiinflammatory agents; antiallergens; antiarthritic agents
11/13/2003US20030212066 1-Sulfonyl pyrrolidine derivatives
11/13/2003US20030212044 Treatment of HIV
11/13/2003US20030212032 Oligonucleotide N3'→P5' thiophosphoramidates: their synthesis and use
11/13/2003US20030212026 Induce immunology response
11/13/2003US20030212012 Prevention labor contraction; urogenital disorders
11/13/2003US20030212011 Macrolides with antibacterial activity
11/13/2003US20030212010 23-O-substituted 5-O-mycaminosyltylonide derivatives
11/13/2003US20030211996 Virus like particles
11/13/2003US20030211995 Therapy for drug resistance bacteria
11/13/2003US20030211969 Administering activated protein c; controlling blood coagulation
1 ... 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 ... 1798